Have a feature idea you'd love to see implemented?
Let us know!
INSM INSMED Inc
Price (delayed)
$73.15
Market cap
$13.09B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.55
Enterprise value
$13.79B
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved
Highlights
The company's quick ratio has surged by 137% QoQ and by 39% YoY
INSM's revenue is up by 22% year-on-year and by 4.4% since the previous quarter
INSMED's net income has decreased by 19% YoY and by 8% QoQ
The EPS has declined by 4.9% year-on-year and by 3% since the previous quarter
Key stats
What are the main financial stats of INSM
Market
Valuations
Earnings
Shares outstanding
178.9M
Market cap
$13.09B
Enterprise value
$13.79B
Price to earnings (P/E)
N/A
Price to book (P/B)
26
Price to sales (P/S)
37.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.2
Revenue
$342.96M
EBIT
-$776.7M
EBITDA
-$762.68M
Free cash flow
-$636.03M
Per share
Balance sheet
Liquidity
EPS
-$5.55
Free cash flow per share
-$3.66
Book value per share
$2.81
Revenue per share
$1.97
TBVPS
$10.69
Total assets
$2.05B
Total liabilities
$1.57B
Debt
$1.16B
Equity
$483.42M
Working capital
$1.39B
Debt to equity
2.4
Current ratio
6.37
Quick ratio
5.83
Net debt/EBITDA
-0.92
Margins
Efficiency
Dividend
EBITDA margin
-222.4%
Gross margin
77.2%
Net margin
-252%
Operating margin
-240.9%
Return on assets
-54.4%
Return on equity
N/A
Return on invested capital
-47%
Return on capital employed
-43.3%
Return on sales
-226.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSM stock price
How has the INSMED stock price performed over time
Intraday
-0.89%
1 week
10.35%
1 month
-0.72%
1 year
208.26%
YTD
136.04%
QTD
0.21%
Financial performance
How have INSMED's revenue and profit performed over time
Revenue
$342.96M
Gross profit
$264.92M
Operating income
-$826.11M
Net income
-$864.29M
Gross margin
77.2%
Net margin
-252%
INSM's revenue is up by 22% year-on-year and by 4.4% since the previous quarter
INSMED's operating income has decreased by 21% YoY and by 9% QoQ
The company's gross profit rose by 20% YoY and by 3.9% QoQ
INSMED's net income has decreased by 19% YoY and by 8% QoQ
Growth
What is INSMED's growth rate over time
Valuation
What is INSMED stock price valuation
P/E
N/A
P/B
26
P/S
37.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.2
The EPS has declined by 4.9% year-on-year and by 3% since the previous quarter
INSM's price to sales (P/S) is 126% higher than its 5-year quarterly average of 16.4 and 55% higher than its last 4 quarters average of 23.9
INSM's revenue is up by 22% year-on-year and by 4.4% since the previous quarter
Efficiency
How efficient is INSMED business performance
The ROIC has declined by 20% year-on-year
The company's return on assets fell by 12% YoY but it rose by 4.7% QoQ
The ROS has declined by 3.9% since the previous quarter
Dividends
What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSM.
Financial health
How did INSMED financials performed over time
INSM's total assets is 31% higher than its total liabilities
The company's quick ratio has surged by 137% QoQ and by 39% YoY
The current ratio has soared by 135% from the previous quarter and by 35% YoY
The debt is 140% more than the equity
The debt to equity has soared by 151% YoY but it has plunged by 93% from the previous quarter
The debt has contracted by 16% from the previous quarter and by 14% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.